Eating Disorder Outlook 2025: M&A On the Rise, GLP-1s Impact Treatment

January 2, 2025

Featuring:
Goran Dragolovic

In this Behavioral Health Business article, reporter Morgan Gonzales shares the industry forecast for 2025 with insight from executives, including ERC Pathlight's CEO Goran Dragolovic.

The eating disorder treatment sector has transformed dramatically in the past few years, with 2025 poised to bring further disruption through virtual care expansion, market consolidation and evolving patient needs.

This evolution is occurring on the heels of a string of notable eating disorder treatment facility closures in 2023 and 2024.

Despite the shuttering of multiple players in the field, 2025 will be a prime year for increased investment, de novo growth and mergers and acquisitions, according to top industry leaders.

Providers looking to thrive must still hone their research, clinical and growth techniques. Focusing on cutting-edge treatments, coping with new challenges, including GLP-1 medications’ impact on eating disorders, and advocating for reduced stigma will keep providers occupied in the new year.

Read the Full Article

Eating Recovery Center is accredited through the Joint Commission. This organization seeks to enhance the lives of the persons served in healthcare settings through a consultative accreditation process emphasizing quality, value and optimal outcomes of services.

Organizations that earn the Gold Seal of Approval™ have met or exceeded The Joint Commission’s rigorous performance standards to obtain this distinctive and internationally recognized accreditation. Learn more about this accreditation here.

joint commission gold seal